Late Onset of Migraine With Aura Linked to Increased Stroke Risk in Late Life
The study underscores the importance of migraine with aura symptom onset in the evaluation of ischemic stroke risk in late life.
All articles by Sheila Jacobs
Mechanical Joint Loading as an Alternative Model for OA-Associated Pain
Researchers pharmacologically confirmed the pain phenotype of a noninvasive mechanical joint-loading model of osteoarthritis, thus proposing an alternative murine model for osteoarthritic pain.
Knee Pain May Be Predictive of Structural Progression in Patients With OA
Knee pain predicted accelerated cartilage volume loss and increased risk for incident radiographic osteoarthritis.
High Daily Stress Linked to Migraine Prevalence in Women
The investigators sought to evaluate the prevalence of migraines, as well as the effect of sex and stress on migraines.
Differentiation of Knee Pain Phenotypes Among Older Adults
A population-based, cohort study was conducted to identify knee pain in a group of older adults.
Utility of Repeated Sacroiliac Joint MRI in Chronic Back Pain, Suspected axSpA
Findings suggest that repeating MRI of the sacroiliac joints after 3 months or 1 year in patients with chronic back pain and suspected axial spondyloarthritis was not useful.
Chronic Migraine and Medication Overuse Headache Linked to Stress
The investigators sought to evaluate whether early-life traumatic experiences, stressful life events, and alexithymia are associated with chronic migraine and medication overuse headache.
Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA
Widespread nonarthritic pain is linked to worse patient-reported and composite psoriatic arthritis activity measures.
Adalimumab Reduces Skin Pain in Hidradenitis Suppurativa
Outcomes were examined in 2 randomized, double-blind, placebo-controlled, parallel-group clinical trials: PIONEER I (ClinicalTrials.gov identifier: NCT01468207) and PIONEER II (ClinicalTrials.gov identifier: NCT01468233).
Efficacy, Safety of OnabotulinumtoxinA Assessed for Knee OA Treatment
Investigators sought to evaluate intra-articular onabotulinumtoxinA 400 U and 200 U in reducing symptoms of knee OA in patients with nociceptive pain.
Next post in Rheumatology
